ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 332 filers reported holding ROYALTY PHARMA PLC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $44,278,790 | +89.2% | 1,679,135 | +117.9% | 0.07% | +89.2% |
| Q1 2024 | $23,405,552 | -59.7% | 770,680 | -62.7% | 0.04% | -67.3% |
| Q4 2023 | $58,020,653 | +25.0% | 2,065,527 | +20.7% | 0.11% | -6.6% |
| Q3 2023 | $46,433,066 | +28.1% | 1,710,872 | +45.1% | 0.12% | -8.3% |
| Q2 2023 | $36,253,004 | +134.7% | 1,179,343 | +175.1% | 0.13% | +100.0% |
| Q1 2023 | $15,448,115 | -50.6% | 428,757 | -45.9% | 0.07% | -60.7% |
| Q4 2022 | $31,301,618 | +141.0% | 792,045 | +145.0% | 0.17% | +118.2% |
| Q3 2022 | $12,990,000 | +448.6% | 323,283 | +473.9% | 0.08% | +352.9% |
| Q2 2022 | $2,368,000 | -77.5% | 56,330 | -79.1% | 0.02% | -80.9% |
| Q1 2022 | $10,513,000 | +350.4% | 269,853 | +360.8% | 0.09% | +394.4% |
| Q4 2021 | $2,334,000 | -22.4% | 58,568 | -29.6% | 0.02% | -52.6% |
| Q3 2021 | $3,007,000 | -15.6% | 83,204 | -4.3% | 0.04% | -7.3% |
| Q2 2021 | $3,564,000 | +18.1% | 86,946 | +21.2% | 0.04% | -4.7% |
| Q3 2020 | $3,018,000 | – | 71,728 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |